Related Experiment Video
Updated: Aug 21, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Inhibition of cell proliferation by potential peroxisome proliferator-activated receptor (PPAR) gamma agonists and
Michael A Lea1, Monali Sura, Charles Desbordes
1Department of Biochemistry and Molecular Biology, UMDNJ - New Jersey Medical School, Newark, New Jersey 07103, USA. lea@umdnj.edu
Abstract:
This study was initiated to determine if potential PPAR gamma antagonists could block the inhibition of cell proliferation caused by 4-phenylbutyrate. The action of 4-phenylbutyrate differed from other PPAR gamma ligands examined in that it induces histone acetylation. Proliferation of DS19 mouse erythroleukemia cells was inhibited by PPAR gamma agonists (4-phenylbutyrate, rosiglitazone, ciglitazone and GW1929) and by potential PPAR gamma antagonists: BADGE (Biphenol A diglycidyl ether), GW9662, PD068235 and diclofenac. Combined incubations tended to exhibit additive inhibitory effects. Potential PPAR gamma agonists and antagonists inhibited the incorporation of thymidine into DNA of human prostate (PC3), colon (Caco-2) and breast (T47D) cancer cells but also affected NIH3T3 cells that have little or no expression of PPAR gamma. Lipid accumulation in T47D cells was seen after incubation with 4-phenylbutyrate and both potential PPAR gamma agonists and antagonists. The extent to which the effects of 4-phenylbutyrate on cell proliferation are mediated through PPAR gamma or induction of histone acetylation remains an open question. We conclude that potential PPAR gamma antagonists may fail to reverse the growth inhibitory effect of PPAR gamma ligands and may themselves act as growth inhibitory agents.
Insights
PPAR gamma antagonists did not block 4-phenylbutyrate
Area of Science:
- Cell biology
- Molecular biology
- Cancer research
Background:
- Peroxisome proliferator-activated receptor gamma (PPARγ) is a nuclear receptor involved in various cellular processes.
- PPARγ ligands, including agonists and antagonists, are being investigated for their role in cell proliferation and cancer.
- 4-phenylbutyrate, a PPARγ ligand, also induces histone acetylation, suggesting alternative mechanisms of action.
Purpose of the Study:
- To investigate whether potential PPARγ antagonists could counteract the cell proliferation inhibition caused by 4-phenylbutyrate.
- To explore the effects of PPARγ agonists and antagonists on cancer cell proliferation and lipid accumulation.
- To determine the role of PPARγ and histone acetylation in the cellular effects of 4-phenylbutyrate.
Main Methods:
- Utilized DS19 mouse erythroleukemia cells and human cancer cell lines (PC3, Caco-2, T47D).
- Treated cells with PPARγ agonists (4-phenylbutyrate, rosiglitazone, ciglitazone, GW1929) and antagonists (BADGE, GW9662, PD068235, diclofenac).
- Assessed cell proliferation via thymidine incorporation and observed lipid accumulation.
Main Results:
- Both PPARγ agonists and antagonists inhibited cell proliferation across various cancer cell lines and NIH3T3 cells.
- Combined treatments showed additive inhibitory effects on cell proliferation.
- Lipid accumulation was observed in T47D cells treated with 4-phenylbutyrate and both agonist/antagonist types.
Conclusions:
- Potential PPARγ antagonists may not reverse the growth-inhibitory effects of PPARγ ligands.
- PPARγ antagonists themselves can exhibit growth-inhibitory properties.
- The precise mechanisms by which 4-phenylbutyrate affects cell proliferation, whether via PPARγ or histone acetylation, require further investigation.
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
GPCRs Regulate Adenylyl Cylase Activity
Two...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation
Negative Regulator Molecules
Cell Specific Gene Expression